Ohr Pharmaceutical, Inc.
(NASDAQ : OHRP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.59%93.741.3%$968.18m
BIIBBiogen Inc.
-0.80%225.371.3%$897.71m
GILDGilead Sciences, Inc.
-0.94%62.660.9%$410.38m
AMGNAmgen Inc.
-2.35%178.181.2%$410.07m
ILMNIllumina, Inc.
-0.22%318.003.5%$276.86m
REGNRegeneron Pharmaceuticals, Inc.
-2.52%334.342.6%$236.48m
VRTXVertex Pharmaceuticals Incorporated
0.32%167.501.9%$220.78m
ONCESpark Therapeutics, Inc.
-0.41%110.2611.2%$169.08m
ALXNAlexion Pharmaceuticals, Inc.
-0.49%125.292.0%$164.53m
EXASExact Sciences Corporation
0.15%91.9525.3%$151.34m
SRPTSarepta Therapeutics, Inc.
-1.84%116.5514.7%$138.78m
AAgilent Technologies, Inc.
0.95%76.151.6%$121.23m
INCYIncyte Corporation
-2.19%72.692.5%$89.94m
IONSIonis Pharmaceuticals, Inc.
-0.36%72.418.3%$88.04m
BMRNBioMarin Pharmaceutical Inc.
0.84%83.054.3%$85.35m

Company Profile

Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY.